{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:13:11Z","timestamp":1761869591240,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Interventional Medicine"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jimed.2021.12.004","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T02:22:17Z","timestamp":1639102937000},"page":"10-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of tumor response following conventional versus drug-eluting bead transarterial chemoembolization in early- and very early-stage hepatocellular carcinoma"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8002-4763","authenticated-orcid":false,"given":"Murtuza","family":"Razi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed","family":"Safiullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Razi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jimed.2021.12.004_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jimed.2021.12.004_bib2","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jimed.2021.12.004_bib3","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jimed.2021.12.004_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1148\/radiol.2241011262","article-title":"Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials","volume":"224","author":"Camm\u00e0","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.jimed.2021.12.004_bib5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","article-title":"Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival","volume":"37","author":"Llovet","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jimed.2021.12.004_bib6","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005606","article-title":"The incidence and outcome of major complication following conventional TAE\/TACE for hepatocellular carcinoma","volume":"95","author":"Tu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jimed.2021.12.004_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3348\/kjr.2018.0088","article-title":"Update on transarterial chemoembolization with drug-eluting microspheres for hepatocellular carcinoma","volume":"20","author":"Nouri","year":"2019","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.jimed.2021.12.004_bib8","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1158\/1078-0432.CCR-05-2225","article-title":"New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer","volume":"12","author":"Hong","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jimed.2021.12.004_bib9","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s00270-010-9794-1","article-title":"Doxorubicin-loaded QuadraSphere microspheres: plasma pharmacokinetics and intratumoral drug concentration in an animal model of liver cancer","volume":"33","author":"Lee","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jimed.2021.12.004_bib10","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2006.10.020","article-title":"Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics","volume":"46","author":"Varela","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jimed.2021.12.004_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3348\/kjr.2015.16.1.125","article-title":"Transarterial chemoembolization using gelatin sponges or microspheres plus lipiodol-doxorubicin versus doxorubicin-loaded beads for the treatment of hepatocellular carcinoma","volume":"16","author":"Liu","year":"2015","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.jimed.2021.12.004_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","article-title":"Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study","volume":"33","author":"Lammer","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jimed.2021.12.004_bib13","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3350\/cmh.2015.21.4.344","article-title":"Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: now and future","volume":"21","author":"Woo","year":"2015","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jimed.2021.12.004_bib14","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/jgh.13147","article-title":"Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma","volume":"31","author":"Facciorusso","year":"2016","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jimed.2021.12.004_bib15","first-page":"11","article-title":"Conventional versus drug-eluting bead transarterial chemoembolization: a better option for treatment of unresectable hepatocellular carcinoma","volume":"4","author":"Razi","year":"2021","journal-title":"J\u00a0Interv Med"}],"container-title":["Journal of Interventional Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2096360221000727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2096360221000727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:08:15Z","timestamp":1761869295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2096360221000727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2096360221000727"],"URL":"https:\/\/doi.org\/10.1016\/j.jimed.2021.12.004","relation":{},"ISSN":["2096-3602"],"issn-type":[{"type":"print","value":"2096-3602"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of tumor response following conventional versus drug-eluting bead transarterial chemoembolization in early- and very early-stage hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Interventional Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jimed.2021.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Shanghai Journal of Interventional Radiology Press. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}